Particle.news

Download on the App Store

CaixaImpulse Marks 10th Anniversary as Supported Devices Near Market Debut

Mobilizing nearly €25 million to translate biomedical research into clinical applications, the program is set to sustain or grow its €5 million annual budget.

José Carlos Pulido, CEO de Inrobics; Laura Sampietro, subdirectora de Innovación el Hospital Clínic; Àngel Font, , subdirector general de Investigación y Becas de la Fundación La Caixa; Pablo Cironi, director de Criteria Bio Ventures; Alicia Martínez Piñeiro, CEO de Time is Brain; y Rubén Molina, CEO de Innitius
De izquierda a derecha, José Carlos Pulido, CEO de Inrobics;Laura Sampietro-Colom, adjunta de Innovación del Hospital Clínic y mentora del programa;Àngel Font, subdirector general de Investigación y Becas de la Fundación La Caixa;Pablo Cironi, director de Criteria Bio Ventures; Alicia Martínez Piñeiro, CEO de Time is Brain, y Rubén Molina, CEO de Innitius

Overview

  • Since its launch in 2015, CaixaImpulse has invested €24.8 million across 232 projects in Spain and Portugal.
  • Backed initiatives have yielded 50 spin-offs, four innovation licenses and over 19 clinical trials.
  • Participating researchers have received up to €700,000 per project through a three-phase funding pathway, alongside more than 5,500 hours of mentorship and 870 hours of training.
  • Supported ventures have attracted over €180 million in additional financing, multiplying program investment sevenfold.
  • Several medical devices developed through the program—including a real-time brain monitor and a uterine sensor—are slated to launch this year.